← back to search

Geoffroy Durand

Lund University · SE
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Breast cancer and Missense mutation, with related work in Genetics, Epigenetics, Renal cell carcinoma. Notable publications include 'DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility', 'Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids', and 'Genome-wide association study identifies multiple risk loci for renal cell carcinoma'.
h-index
citations
1,004
works
13
NIH funding
primary concept
email

Recent publications

Spatial Multiomics Reveals Intratumoral Immune Heterogeneity with Distinct Cytokine Networks in Lung Cancer Brain Metastases
Cancer Research Communications 2024cited by 6position: middledoi
Hepatitis B virus preS2Δ38–55 variants: A newly identified risk factor for hepatocellular carcinoma
JHEP Reports 2020cited by 28position: middledoi
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
Nature Communications 2019cited by 209position: middledoi
Sex specific associations in genome wide association analysis of renal cell carcinoma
European Journal of Human Genetics 2019cited by 45position: middledoi
DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility
European Journal of Cancer 2017cited by 214position: middledoi
Genome-wide association study identifies multiple risk loci for renal cell carcinoma
Nature Communications 2017cited by 140position: middledoi
Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines
Scientific Reports 2017cited by 33position: middledoi
No evidence that protein truncating variants in <i>BRIP1</i> are associated with breast cancer risk: implications for gene panel testing
Journal of Medical Genetics 2016cited by 103position: middledoi
Multigene testing of moderate-risk genes: be mindful of the missense
Journal of Medical Genetics 2016cited by 35position: middledoi
<i>CASP9</i> germline mutation in a family with multiple brain tumors
Brain Pathology 2016cited by 26position: middledoi
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study
Breast Cancer Research 2014cited by 109position: middledoi
TP53, MSH4, and LATS1 Germline Mutations in a Family with Clustering of Nervous System Tumors
American Journal Of Pathology 2014cited by 24position: middledoi
RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study
PLoS ONE 2012cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2012–2020)Catherine Voegele · Matrix Research (United States)5 papers (2012–2020)Fabienne Lesueur · Inserm2 papers (2012–2014)James McKay · University of Miami2 papers (2014–2016)Melissa C. Southey · Monash Health2 papers (2012–2014) · 2 papers (2014–2016)Francesca Damiola · Université Claude Bernard Lyon 12 papers (2012–2014)Michel Mittelbronn · Centre Hospitalier de Luxembourg2 papers (2014–2016)John L. Hopper · National Institute on Deafness and Other Communication Disorders2 papers (2012–2014) · 2 papers (2012–2014) · 2 papers (2012–2014)Esther M. John · Palo Alto University2 papers (2012–2014)Irene L. Andrulis · University of Toronto2 papers (2012–2014)Maxime Vallée · Université Laval2 papers (2012–2014)Sean V. Tavtigian · University of Utah2 papers (2012–2014) · 2 papers (2012–2014)Nora Kakwata-Nkor Deluce · Université Claude Bernard Lyon 11 papers (2020–2020)Gibril Ndow · London School of Hygiene & Tropical Medicine1 papers (2020–2020)Zdenko Herceg · National Heart Lung and Blood Institute1 papers (2017–2017)Céline Brochier‐Armanet · Université Claude Bernard Lyon 11 papers (2020–2020)